Plain-English translation of NCT04934787 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new wearable robotic ankle-foot device called an exoneuromusculoskeleton with balance sensing feedback (ENMS-BSF) to help people recover their walking ability after a stroke. The device combines soft robotic assistance, electrical stimulation, and balance feedback to help correct foot drop (when your foot drags) and improve how your leg muscles work together. Researchers believe that using this device during rehabilitation sessions could help restore more normal walking patterns.
After a stroke, many people struggle with foot drop and difficulty walking safely. Current rehabilitation methods have limited success in restoring normal walking function. This trial aims to see whether this new robotic device can provide better, longer-lasting improvements in walking and balance compared to standard rehabilitation alone.
You likely qualify if…
You likely don't qualify if…
If you join this study, you would attend 20 gait rehabilitation sessions while wearing the robotic ankle device. Depending on which group you're assigned to, you would receive full robotic assistance, partial assistance, or wear the device without active assistance (a comparison group). During each session, you would practice walking with the device, which is lightweight and worn on one leg. The study is designed to see how well the device helps improve your walking over time.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
China